Literature DB >> 1638633

A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s).

X Y Fu1.   

Abstract

Interferon-stimulated gene factor 3 (ISGF3), the primary transcription factor induced by interferon alpha, is a complex of four (113, 91, 84, and 48 kd) proteins. This paper reports that the 113, 91, and 84 kd (ISGF3 alpha) proteins of ISGF3 contain conserved SH2 and SH3 domains. A specific interferon alpha-induced cytoplasmic protein tyrosine kinase(s) can form a transient complex with ISGF3 alpha proteins. These ISGF3 alpha proteins can be immunoprecipitated by anti-phosphotyrosine antibodies only after interferon alpha treatment. Phosphoamino acid analyses of 32P-labeled ISGF3 alpha proteins confirm that ISGF3 alpha proteins are directly tyrosine phosphorylated both in vitro and in vivo in response to interferon alpha, and this tyrosine phosphorylation can be inhibited by staurosporine and genistein. Phosphatase treatment of these ISGF3 alpha proteins results in inhibition of ISGF3 complex formation in vitro. These observations indicate that interferon alpha-induced direct tyrosine phosphorylation of ISGF3 alpha proteins is necessary for activation of the transcription factor ISGF3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638633     DOI: 10.1016/0092-8674(92)90106-m

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  92 in total

1.  STAT1 from the cell membrane to the DNA.

Authors:  B F Lillemeier; M Köster; I M Kerr
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis.

Authors:  Y E Chin; M Kitagawa; K Kuida; R A Flavell; X Y Fu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 4.  The role of signal transducer and activator of transcription-2 in the interferon response.

Authors:  Håkan C Steen; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

5.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  In vitro activation of the transcription factor gamma interferon activation factor by gamma interferon: evidence for a tyrosine phosphatase/kinase signaling cascade.

Authors:  K Igarashi; M David; D S Finbloom; A C Larner
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  Inhibition of Stat1-mediated gene activation by PIAS1.

Authors:  B Liu; J Liao; X Rao; S A Kushner; C D Chung; D D Chang; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA.

Authors:  C E Grant; M Z Vasa; R G Deeley
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

9.  The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage.

Authors:  A Eilers; D Seegert; C Schindler; M Baccarini; T Decker
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3.

Authors:  R N Pearse; R Feinman; K Shuai; J E Darnell; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.